Latest Lead News

Yugo Metals has received formal government approval for its 100%-owned Petrovo tenement in Bosnia and Herzegovina, opening the door to advance one of Europe’s most promising high-grade polymetallic systems. Exceptional grades of nickel, zinc, lead, antimony, gold, and silver have been confirmed, setting the stage for a new phase of exploration.

D3 Energy has raised $6.12 million through a strongly supported placement at a significant premium to its IPO price, aiming to accelerate exploration and development of its helium assets amid tightening global supply.

Desert Minerals has launched a targeted drilling campaign at its Scotty Lithium Project in Nevada, aiming to define near-surface lithium mineralisation and support a maiden resource estimate. The project sits in a prolific lithium district adjacent to one of North America’s largest lithium deposits.

Cyclopharm has secured a significant multi-site agreement with the University of Pennsylvania Health System, marking a major step in its US expansion with installations across 11 clinical locations.

Triangle Energy has secured joint funding with Tetragon and Winchester Energy to undertake a strategic exploration study in Indonesia, potentially paving the way for a new production sharing contract.

Minerals 260 secures Foreign Investment Review Board approval, enabling Franco-Nevada to complete a $220 million funding package that accelerates development of the Bullabulling Gold Project.

Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.

Enlitic has secured a $1.5 million contract to migrate over 71 million clinical files for Penn Medicine Doylestown Health, reinforcing its foothold in the US healthcare IT sector.

Insignia Financial has secured a crucial regulatory approval from APRA, advancing the proposed acquisition by Daintree BidCo. The deal now moves closer to a shareholder vote scheduled for mid-April.

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.

ABx Group’s mixed rare earth carbonate from Tasmania’s Deep Leads project has earned strong validation from US-based Rare Earth Technologies Inc, confirming its high purity and compatibility with cutting-edge separation technology.

AdAlta Limited has been granted a key Canadian patent for its anti-fibrotic drug AD-214, completing its composition of matter protection across all major commercial markets. This milestone strengthens the company’s intellectual property portfolio and underpins its commercial strategy for AD-214.